Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myotonic Dystrophy Type 2”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Large-scale testing (Phase 3)Study completedNCT03610412
What this trial is testing

Cinnamomum Cassia Effect on IGF1 and Metabolic Control in Patients With DM2 Without Glycemic Control Metformin Treated

Who this might be right for
Diabetes Mellitus, Type 2
Coordinación de Investigación en Salud, Mexico 28
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Not applicableLooking for participantsNCT05854433
What this trial is testing

Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2

Who this might be right for
Myotonic Dystrophy Type 2Myotonic Dystrophy Type 1
Wake Forest University Health Sciences 100
Not applicableUnknownNCT02931773
What this trial is testing

Autonomic Cardiovascular Neuropathy in Recently Diagnosed DM2 Patients (ACNDM2)

Who this might be right for
Dysautonomia
Instituto Nacional de Cardiologia Ignacio Chavez 60
Not applicableUnknownNCT04932356
What this trial is testing

Telephone Therapeutic Education Program in DM2 Patients With Poor Metabolic Control

Who this might be right for
Diabetes Mellitus, Type 2
Mª Dolores Rodríguez Garrido 76
Not applicableStudy completedNCT03168633
What this trial is testing

Lifestyle Advises Sent Via Email in Attempt of Improving A1C in DM2 Patients

Who this might be right for
Diabetes Mellitus, Type 2
Rambam Health Care Campus 50
Testing effectiveness (Phase 2)WithdrawnNCT04626089
What this trial is testing

Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2Metabolic SyndromeType 2 Diabetes
Laboratorios Silanes S.A. de C.V.
Not applicableWithdrawnNCT03277742
What this trial is testing

Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz

Who this might be right for
Pulmonary TuberculosisDiabetes Mellitus, Type 2
Instituto Nacional de Salud Publica, Mexico
Large-scale testing (Phase 3)Enrolling By InvitationNCT06549400
What this trial is testing

An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Who Have Completed MEX-DM-302 Study.

Who this might be right for
Myotonic Dystrophy
Lupin Ltd. 176
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Early research (Phase 1)Study completedNCT01437800
What this trial is testing

BIOAVAILABILITY OF GLI/METXR (4/850 mg)

Who this might be right for
Healthy
Laboratorios Silanes S.A. de C.V. 24
Large-scale testing (Phase 3)UnknownNCT03051243
What this trial is testing

Safety and Efficiency of Linagliptin (Trajenta) in the Setting of Internal Medicine Department

Who this might be right for
DM2
Rabin Medical Center 60
Not applicableEnrolling By InvitationNCT06605612
What this trial is testing

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyLimb-girdle and Facioscapulohumeral Muscular Dystrophies+9 more
LMU Klinikum 108
Testing effectiveness (Phase 2)Study completedNCT06624553
What this trial is testing

Satisfaction With FreeStyle Libre 2 Monitoring Versus Capillary Blood Glucose Monitoring in People With DM2

Who this might be right for
Diabetes Mellitus, Type 2
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 50
Not applicableStudy completedNCT04800471
What this trial is testing

Improving Glycemic Control in DM2 Patients in the Ambulatory Setting

Who this might be right for
Diabetes Mellitus
University of Maryland, Baltimore 30
Not applicableLooking for participantsNCT07136844
What this trial is testing

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

Who this might be right for
Neuromuscular DiseasesObesity (Disorder)Myotonic Dystrophy 1+9 more
Centre Hospitalier Universitaire de Liege 300
Not applicableUnknownNCT01627509
What this trial is testing

Comparison of Two Insulin Regimens in Optimally-controlled Patients With DM2.

Who this might be right for
Diabetes Mellitus 2 Type
Sheba Medical Center 40
Not applicableNot Yet RecruitingNCT07128342
What this trial is testing

CGM Use in Non-insulin Patients With DM2

Who this might be right for
DiabetesType 2 Diabetes (T2DM)Obesity Type 2 Diabetes Mellitus+1 more
Milwaukee VA Medical Center 100
Not applicableLooking for participantsNCT06638567
What this trial is testing

Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.

Who this might be right for
Diabetes Mellitus, Type 2Surgical Site Infection
Abraham Hulst, MD, PhD 1,008
Not applicableStudy completedNCT04473430
What this trial is testing

Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)

Who this might be right for
End-Stage Renal DiseaseType 2 Diabetes
Emory University 53
Load More Results